Abstract
Between 30 and 60% of HIV-seropositive individuals develop symptoms of clinical depression and/or apathy. Dopamine and serotonin are associated with motivational alterations; however, histamine is less well studied. In the present study, we used fast-scan cyclic voltammetry in HIV-1 transgenic (Tg) rats to simultaneously analyze the kinetics of nucleus accumbens dopamine (DA), prefrontal cortical serotonin (5-HT), and hypothalamic histamine (HA). For voltammetry, subjects were 15 HIV-1 Tg (7 male, 8 female) and 20 F344/N (11 male, 9 female) adult rats. Both serotonergic and dopaminergic release and reuptake kinetics were decreased in HIV-1 Tg animals relative to controls. In contrast, rates of histamine release and reuptake increased in HIV-1 Tg rats. Additionally, we used immunohistochemical (IHC) methods to identify histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus. For IHC, subjects were 9 HIV-1 Tg (5 male, 4 female) and 9 F344/N (5 male, 4 female) adult rats. Although the total number of TMN histaminergic cells did not differ between HIV-1 Tg rats and F344/N controls, a significant sex effect was found, with females having an increased number of histaminergic neurons, relative to males. Collectively, these findings illustrate neurochemical alterations that potentially underlie or exacerbate the pathogenesis of clinical depression and/or apathy in HIV-1.
Similar content being viewed by others
References
Aksenov MY, Aksenova MV, Silvers JM, Mactutus CF, Booze RM (2008) Different effects of selective dopamine uptake inhibitors GBR 12909 and WIN 35428 on HIV-1 Tat toxicity in rat fetal midbrain neurons. Neurotoxicology 29:971–977
Becker JB (2016) Sex differences in addiction. Dialogues Clin Neurosci 18:395–402
Becker JB, McClellan M, Reed BG (2016) Sociocultural context for sex differences in addiction. Addict Biol 21:1052–1059
Bertrand SJ, Aksenova MV, Mactutus CF, Booze RM (2013) HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. Exp Neurol 248:228–235
Bertrand SJ, Mactutus CF, Harrod SB, Moran LM, Booze RM (2018) HIV-1 proteins dysregulate motivational processes and dopamine circuitry. Sci Rep 8:7869. https://doi.org/10.1038/s41598-018-25109-0
Bhatia MS, Munjal S (2014) Prevalence of depression in people living with HIV/AIDS undergoing ART and factors associated with it. J Clin Diagn Res 8:WC01–WC04
Blandina P, Munari L, Provensi G, Passani MB (2012) Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations? Front Syst Neurosci 6:33. https://doi.org/10.3389/fnsys.2012.00033
Booze RM, Wood ML, Welch MA, Berry S, Mactutus CF (1999) Estrous cyclicity and behavioral sensitization in female rats following repeated intravenous cocaine administration. Pharmacol Biochem Behav 64:605–610
Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Prog Neurobiol 63:637–672
Bryant VE, Whitehead NE, Burrell LE, Dotson VM, Cook RL, Malloy P, Devlin K, Cohen RA (2015) Depression and apathy among people living with HIV: implications for treatment of HIV associated neurocognitive disorders. AIDS Behav 19:1430–1437
Castellon SA, Hinkin CH, Wood S, Yarema KT (1998) Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychol 10:320–328
Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, [ … ] Millar G.W. (2007) Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27:8138–8148
Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS (2008) Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage 42:869–878
Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 216:86–98
Ericson H, Watanabe T, Köhler C (1987) Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol 263:1–24
Ericson H, Blomqvist A, Köhler C (1989) Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation. J Comp Neurol 281:169–192
Eshun-Wilson L, Siegfried N, Akena DH, Stein DJ, Obuku EA, Joska JA (2018) Antidepressants for depression in adults with HIV infection. Cochrane Database Syst Rev 1:CD008525. https://doi.org/10.1002/14651858.cd008525.pub3
Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32:883–909
Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2009a) The human immunodeficiency virus-1-associated protein TAT1-86 impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study. Neurosci 10:1292–1299
Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2009b) In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 tat-induced alterations in dopamine transmission. Synapse 63:181–185
Fitting S, Booze RM, Hasselrot U, Mactutus CF (2008) Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study. Hippocampus 18:135–147
Fitting S, Booze RM, Mactutus CF (2015) HIV-1 proteins, Tat and gp120, target the developing dopamine system. Curr HIV Res 13:21–42
Fletcher PJ, Selhi ZF, Azampanah A, Sills TL (2001) Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenyalanine. Neuropsychopharmacology 24:399–409
Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4:121–130
Hashemi P, Dankoski EC, Petrovi J, Keithley RB, Wightman RM (2009) Voltammetric detection of 5-hydroxytryptamine release in the rat brain. Anal Chem 81:9462–9471
Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR, Imasuku ML, Kalima K, Heaton RK (2012) Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection. J Nerv Ment Dis 200:336–342. https://doi.org/10.1097/NMD.0b013e31824cc225
Javadi-Paydar M, Roscoe RF, Denton AR, Mactutus CF, Booze RM (2017) HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum. 12: e0188404 Doi: https://doi.org/10.1371/journal.pone.0188404
Kamat R, Woods SP, Marcotte TD, Ellis RJ, Grant I (2012) Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Arch Clin Neuropsychol 27:520–531
Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M (2011) Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neuro-Oncol 17:26–40
Maki PM, Rubin LH, Springer G, Seaberg EC, Sacktor N, Miller EN, Valcour V, Young MA, Becker JT, Martin EM (2018) Differences in cognitive function between women and men with HIV. J Acquir Immune Defic Syndr 79:101–107
Marin RS, Firinciogullari S, Biedrzycki RC (1993) The sources of convergence between measures of apathy and depression. J Affect Discord 28:117–124
Marquine MJ, Ludicello JE, Morgan EE, Brown GG, Letendre SL, Ellis RJ, [ … ] Heaton RK (2014) Frontal systems behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency. Psychiatry Res 215:208–216
McIntosh RC, Rosselli M, Uddin L, Antoni M (2015) Neuropathological sequelae of human immunodeficiency virus and apathy: a review of neuropsychological and neuroimaging studies. Neurosci Biobehav Rev 55:47–164
McLaurin KA, Booze RM, Mactutus CF (2016) Progression of temporal processing deficits in the HIV-1 transgenic rat. Sci Rep 6:32831. https://doi.org/10.1038/srep32831
McLaurin KA, Booze RM, Mactutus CF (2017a) Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1 associated neurocognitive disorders. J Neuro-Oncol 24:229–245
McLaurin KA, Booze RM, Mactutus CF, Fairchild AJ (2017b) Sex matters: robust sex differences in signal detection in the HIV-1 transgenic rat. Front Behav Neurosci 11. https://doi.org/10.3389/fnbeh.2017.00212
McLaurin KA, Cook AK, Li H, League AF, Mactutus CF, Booze RM (2018a) Synaptic connectivity in medium spiny neurons of the nucleus accumbens: a sex-dependent mechanism underlying apathy in the HIV-1 transgenic rat. Front Behav Neurosci 12:285. https://doi.org/10.3389/fnbeh.2018.00285
McLaurin KA, Li H, Booze RM, Mactutus CF (2018b) Disruption of timing: NeuroHIV progression in the post-cART era. Sci Rep 9:827
Midde NA, Gomez AM, Zhu J (2012) HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J NeuroImmune Pharmacol 7:629–639
Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus CF, Bell J, Hauser KF, Mattson M (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14:222–227
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13–25
Owens MJ, Nemeroff CB (1994) Role of the serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288–295
Panula P, Yang HY, Costa E (1984) Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci U S A 81:2572–2576
Paxinos G, Watson C (2014) The rat brain in stereotaxic coordinates. Academic Press, Elsevier
Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Mol Neurobiol 44:102–110
Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N (, Jones O, Doodnauth D, Davis H, Sill A, O’Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M ) Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98:9271–9276
Roscoe R, Mactutus CF, Booze RM (2014) HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens. J NeuroImmune Pharmacol 9:642–653
Rowson SA, Harrell CS, Bekhbat M, Gangavelli A, Wu MJ, Kelly SD, Reddy R, Neigh GN (2016) Neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress. Front Psychiatry 7. https://doi.org/10.3389/fpsyt.2016.00102
Royal W, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, [, Abimiku A’, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC ] Blattner WA (2016) Associations between cognition, gender and monocyte activation among HIV infected individuals in Nigeria. P One 11:2 e0147182 doi:https://doi.org/10.1371/journal.pone.0147182
Samaranayake S, Abdalla A, Robke R, Wood KM, Zeqja A, Hashemi P (2015) In vivo histamine voltammetry in the mouse premammillary nucleus. Analyst 140:3759–3765
Samaranayake S, Abdalla A, Robke R, Nijhout HF, Reed MC, Best J, Hashemi P (2016) A voltammetric and mathematical analysis of histaminergic modulation of serotonin in the mouse hypothalamus. J Neurochem 138:374–383
Silvers JM, Aksenov MY, Akensova MV, Beckly J, Olton P, Mactutus CF, Booze RM (2006) Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains. J Neuro-Oncol 12:40–145
Sinharay S, Lee D, Shah S, Muthusamy S, Papadakis GZ, Ahang X, Maric D, Reid WC, Hammound DA (2017) Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV. J Nucl Med 55:27–33
Threlfell S, Cragg SJ, Kalio I, Turi GF, Coen CW, Greenfield SA (2004) Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulate. J Neurosci 24:8704–8710
Torrealba F, Riberos ME, Contreras M, Valdes JL (2012) Histamine and motivation. Front Syst Neurosci 6:51. https://doi.org/10.3389/fnsys.2012.0051
US Department of Veterans Affairs (2009) Primary care of veterans with HIV. Available from https://www.hiv.va.gov/provider/manual-primary-care/depression.asp
Vigorito M, Connaghan KP, Chang SL (2015) The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun 48:336–349
Wada H, Inagaki N, Yamatodani A, Watanabe T (1991) Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 14:415–418
Watanabe T, Taguchi Y, Hayashi H, Tanaka J, Shiosaka S, Tohyama M, Kubota H, Terano Y, Wada H (1983) Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis. Neurosci Lett 39:249–254
Waynforth HB, Flecknell PA (1992) Experimental and surgical techniques in the rat. Elsevier Science, New York
West MJ (2012) Basic stereology for biologists and neuroscientists. Cold Spring Harbor Laboratory Press
Westwood FR (2008) The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol 36:375–384
World Health Organization (2017). HIV/AIDS global health observatory data. Available from http://www.who.int/gho/hiv/en/
Zhu J, Mactutus CF, Wallace DR, Booze R (2009) HIV-1 Tat-protein-induced rapid and reversible decrease in [3H] dopamine uptake: dissociation of [3H] dopamine uptake and [3H]2β-carbomethoxy-3-β-(4-fluorophenyl) tropane (WIN35,428) binding in rat striatal synaptosomes. J Pharmacol Exp Ther 329:1071–1083
Zhu J, Midde NM, Gomez AM, Sun WL, Quizon PM, Zhan CG (2016) HIV-1 transgenic rats display an increase in [3H] dopamine uptake in the prefrontal cortex and striatum. J Neurovirol 22:282–292
Acknowledgments
The authors acknowledge and thank Dr. Michael Cranston and Dr. Hailong Li for their assistance with this project.
Funding
This research was supported by the National Institute of Health Grants NS100624, DA013137, HD043680, MH106392 & by a National Institute of Health T32 Training Grant 5T32GM081740.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This experiment was conducted in accordance with the recommendations of the National Institute of Health’s Guide for the Care and Use of Laboratory Animals. Research protocols used were approved by the University of South Carolina Institutional Animal Care and Use Committee (assurance number: D16-00028). Additionally, the authors report no conflicts of interest or competing financial interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Denton, A.R., Samaranayake, S.A., Kirchner, K.N. et al. Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure. J. Neurovirol. 25, 540–550 (2019). https://doi.org/10.1007/s13365-019-00754-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-019-00754-x